Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV000770340 | SCV000901774 | uncertain significance | Cardiomyopathy | 2016-03-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000861269 | SCV001001531 | likely benign | Hypertrophic cardiomyopathy | 2023-09-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000770340 | SCV001355846 | likely benign | Cardiomyopathy | 2018-11-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002422654 | SCV002719651 | likely benign | Cardiovascular phenotype | 2022-06-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000861269 | SCV004842407 | likely benign | Hypertrophic cardiomyopathy | 2024-02-05 | criteria provided, single submitter | clinical testing |